The average one-year price target for DocMorris (SWX:DOCM) has been revised to CHF 6,21 / share. This is a decrease of 34.75% from the prior estimate of CHF 9,52 dated February 21, 2026.
The price target is an average of many targets provided by analysts. The latest targets range from a low of CHF 3,54 to a high of CHF 12,60 / share. The average price target represents an increase of 46.92% from the latest reported closing price of CHF 4,23 / share.
What is the Fund Sentiment?
There are 2 funds or institutions reporting positions in DocMorris. This is an decrease of 22 owner(s) or 91.67% in the last quarter. Average portfolio weight of all funds dedicated to DOCM is 0.00%, an increase of 94.88%. Total shares owned by institutions decreased in the last three months by 99.45% to 2K shares.
What are Other Shareholders Doing?
PDN - Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF holds 2K shares representing 0.00% ownership of the company. In its prior filing, the firm reported owning 1K shares , representing an increase of 71.42%. The firm increased its portfolio allocation in DOCM by 5.66% over the last quarter.
Accent Capital Management holds 0K shares representing 0.00% ownership of the company. No change in the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.